Back

Mavacamten/aficamten: treatment initiation and patient monitoring

31 August 2024 (10:00 - 10:20)
Organised by: Logo
Congress Presentation Part of: New Drugs Made Easy: all you need to know about… Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)

2 More presentations in this session

Presentation thumbnail
GLP-1 receptor agonists: treatment initiation and patient monitoring
Professor A. Rosengren (Gothenburg, SE)
Slides
Presentation thumbnail
Tafamidis/acoramidis: treatment initiation and patient monitoring
Doctor S. Cuddy (Boston, US)
Slides

Access the full session

Session thumbnail
New Drugs Made Easy: all you need to know about…
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors
31 August 2025
thumbnail
Webinar
How to organise cardiovascular monitoring during cancer treatment: who, when and how. ESC 2022 Clinical Practice Guidelines - Webinar Series
26 September 2022
thumbnail
Congress Presentation
The effect of mavacamten on electrical parameters in cardiac implantable electronic devices
13 April 2026
thumbnail
Congress Presentation
Pharmacogenetics for mavacamten treatment individualization in patients with obstructive hypertrophic cardiomyopathy
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources